Schmidt W, Von Holst T, Garoff L, Gabelmann J, Kubli F
Eur J Obstet Gynecol Reprod Biol. 1981 Aug;12(2):95-105. doi: 10.1016/0028-2243(81)90022-8.
Monitoring of human follicular development by real-time ultrasound during HMG-HCG treatment is presented. With the aid of ultrasound monitoring, the ovulation rate is raised to 94.3% (formerly 80% without ultrasound). Serious side effects such as ascites and/or hydrothorax did not occur in this study (1.2% without ultrasound controls). The pregnancy rate was 21/47 (44%) of all hormonally treated patients. By means of real-time sector scan examination, the growing follicle could be detected in 103/106 (97.3%) of HMG-HCG treated cycles. Thus real-time ultrasound examinations provide results comparable to those achieved mostly by time-consuming compound scan in demonstration of the growing follicle.
本文介绍了在人绝经期促性腺激素（HMG）-人绒毛膜促性腺激素（HCG）治疗期间通过实时超声监测人类卵泡发育的情况。借助超声监测，排卵率提高到了94.3%（以前未使用超声时为80%）。本研究中未出现诸如腹水和/或胸腔积液等严重副作用（未使用超声对照时为1.2%）。在所有接受激素治疗的患者中，妊娠率为21/47（44%）。通过实时扇形扫描检查，在103/106（97.3%）的HMG-HCG治疗周期中能够检测到生长中的卵泡。因此，在显示生长中的卵泡方面，实时超声检查所提供的结果与大多通过耗时的复合扫描所取得的结果相当。
